Biomarker study for Alzheimer's disease
Part of Brain & nervous system, Mental health clinical trials.
This study uses brain scans or spinal fluid tests to confirm Alzheimer's-related changes. It aims to track the disease over time to better understand and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older
- You are a patient at Xuanwu Hospital in Beijing
- You have mild memory or thinking problems that may be due to Alzheimer's disease
- You have had a positive amyloid PET scan or spinal fluid test showing Alzheimer's-related changes
- You can give your permission to join the study
- You do not have a severe medical or psychological condition that would prevent you from completing the assessments
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for brain/biological “signals” (biomarkers) that may identify Alzheimer’s disease earlier, including stages before clear symptoms. You may be followed for about 5 years, with repeated memory and thinking testing to see how these signs relate to future diagnosis.
This study looks at how to better predict and understand Alzheimer's disease by using advanced brain scans and spinal fluid tests. It aims to find ways to identify people who stay healthy longer despite risk factors.
This study uses brain imaging to understand early changes in Alzheimer's disease. It may help people with or without memory problems learn more about their condition and support future treatments.
This study looks for “biomarkers,” or measurable signs, that help identify Alzheimer’s disease. It may help doctors diagnose Alzheimer’s more accurately by comparing people with Alzheimer’s to others where the diagnosis is different.
This study uses brain scans to find a marker for Alzheimer's disease. It is looking for people with normal memory, mild memory problems, or mild Alzheimer's, and who can undergo a spinal tap and MRI.
This study looks at a specific brain pathway that may be linked to early memory loss in Alzheimer's disease. It compares people with early Alzheimer's to healthy older adults to understand how connections between brain cells start to break down.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.